A coronavirus vaccine likely will become available in the US through an emergency use authorization first, but the Food and Drug Administration still could demand the candidate meet the traditional safety and efficacy requirements, former FDA commissioner Scott Gottlieb said.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?